Antonio Bellasi

7.9k total citations · 1 hit paper
178 papers, 4.5k citations indexed

About

Antonio Bellasi is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonio Bellasi has authored 178 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Nephrology, 56 papers in Cardiology and Cardiovascular Medicine and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonio Bellasi's work include Parathyroid Disorders and Treatments (82 papers), Dialysis and Renal Disease Management (30 papers) and Cardiac Imaging and Diagnostics (22 papers). Antonio Bellasi is often cited by papers focused on Parathyroid Disorders and Treatments (82 papers), Dialysis and Renal Disease Management (30 papers) and Cardiac Imaging and Diagnostics (22 papers). Antonio Bellasi collaborates with scholars based in Italy, United States and Switzerland. Antonio Bellasi's co-authors include Paolo Raggi, Geoffrey A. Block, Biagio Di Iorio, Luca Di Lullo, Domenico Russo, Laura Kooienga, David M. Spiegel, Claudio Ronco, Emiliana Ferramosca and Paul Muntner and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Antonio Bellasi

163 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

2007 561 citations Geoffrey A. Block, Paolo Raggi et al. Kidney International profile →

Peers

Countries citing papers authored by Antonio Bellasi

Since Specialization

Citations

This map shows the geographic impact of Antonio Bellasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Bellasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Bellasi more than expected).

Fields of papers citing papers by Antonio Bellasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Bellasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Bellasi. The network helps show where Antonio Bellasi may publish in the future.

Co-authorship network of co-authors of Antonio Bellasi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Bellasi. A scholar is included among the top collaborators of Antonio Bellasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Bellasi. Antonio Bellasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions 2024 ·Journal of Clinical Medicine ·Edoardo La Porta, Alessandro Faragli, Alexander M. Herrmann, (unknown), (unknown), (unknown), Antonio Bellasi, Giacomo Deferrari, Giovanni Ricevuti, Salvatore Di Somma, Alessio Alogna	3
2	Performance of [18F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis 2024 ·Diagnostics ·Giorgio Treglia, Domenico Albano, Alessio Rizzo, Antonio Bellasi, Andor W.J.M. Glaudemans, Olivier Gheysens	0
3	Prevalence and Characteristics of Upfront Diuretic Resistance in Acute Heart Failure: The P-Value-AHF Study 2024 ·ESC Heart Failure ·(unknown), (unknown), (unknown), (unknown), Melina Stüssi‐Helbling, Pietro E. Cippà, Antonio Bellasi, Lars C Huber, Mattia Arrigo	2
4	Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 2022 ·Nutrients ·Yuri Battaglia, Antonio Bellasi, Alessandra Bortoluzzi, (unknown), Pasquale Esposito, Michele Provenzano, Domenico Russo, Michele Andreucci, Giuseppe Cianciolo, Alda Storari	13
5	Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients 2021 ·INFM-OAR (INFN Catania) ·(unknown), Antonio Bellasi, Sandro Feriozzi	1
6	ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart 2020 ·Arteriosclerosis Thrombosis and Vascular Biology ·Atsushi Sakamoto, Rika Kawakami, Kenji Kawai, Andrea Gianatti, Dario Pellegrini, Robert Kutys, Liang Guo, Masayuki Mori, Anne Cornelissen, Yu Sato, Antonio Bellasi, Lara Faggi, Charles C. Hong, Maria Romero, Giulio Guagliumi, Renu Virmani, Aloke V. Finn	33
7	New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology 2019 ·Journal of Nephrology ·Antonio Bellasi, Mario Cozzolino, Fabio Malberti, Giovanni Cancarini, Ciro Esposito, Carlo Guastoni, Patrizia Ondei, Giuseppe Pontoriero, Ugo Teatini, Giuseppe Vezzoli, Marzia Pasquali, Piergiorgio Messa, Francesco Locatelli	8
8	Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study) 2019 ·Journal of Clinical Medicine ·Biagio Di Iorio, Maria Teresa Rocchetti, Maria De Angelis, Carmela Cosola, Stefania Marzocco, Lucia Di Micco, Ighli di Bari, Matteo Accetturo, Mirco Vacca, Marco Gobbetti, (unknown), Antonio Bellasi, Loreto Gesualdo	94
9	Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis 2019 ·Circulation ·Paolo Raggi, Antonio Bellasi, David A. Bushinsky, Jordi Bover, Mariano Rodríguez, Markus Ketteler, Smeeta Sinha, Carolina Salcedo, (unknown), Claire Padgett, Rekha Garg, Alex Gold, Joan Perelló, Glenn M. Chertow	104
10	Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options 2018 ·Cardiorenal Medicine ·Luca Di Lullo, Claudio Ronco, Antonio Granata, Ernesto Paoletti, Vincenzo Bàrbera, Mario Cozzolino, Maura Ravera, Maria Fusaro, Antonio Bellasi	18
11	[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)]. 2017 ·PubMed ·Giuseppe Quintaliani, Marina Di Luca, Anteo Di Napoli, Giusto Viglino, Maurizio Postorino, Alessandro Amore, Simeone Andrulli, Antonio Bellasi, (unknown), Erasmo Buongiorno, Santina Castellino, Alessandro D’Amelio, Luca De Nicola, (unknown), Domenico Di Landro, Sandro Feriozzi, Giovanni Strippoli, Ugo Teatini, Antonio Santoro	1
12	Uric Acid in Chronic Kidney Disease: A Clinical Appraisal 2016 ·Andrea Galassi, (unknown), (unknown), Antonio Bellasi, Mario Cozzolino	0
13	Vascular Calcification in Chronic Kidney Disease: An Update 2013 ·Mario Cozzolino, (unknown), Paola Ciceri, (unknown), (unknown), Laura Cappelletti, Antonio Bellasi, (unknown)	4
14	Hybrid myocardial imaging for risk stratification prior to kidney transplantation: Added value of coronary calcium and epicardial adipose tissue 2013 ·Journal of Nuclear Cardiology ·Cristina Karohl, Luis D’Marco, Antonio Bellasi, Paolo Raggi	17
15	Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction 2011 ·Clinical Journal of the American Society of Nephrology ·Antonio Bellasi, Marcora Mandreoli, Leopoldo Baldrati, (unknown), Pierpaolo Di Nicolò, (unknown), Antonio Santoro	114
16	La calcificazione vascolare nel paziente con insufficienza renale cronica 2010 ·Recenti Progressi in Medicina ·(unknown), (unknown), (unknown), Antonio Bellasi, Teresa Adragão, (unknown), Giorgio Vescovo, (unknown)	1
17	How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis? 2009 ·Journal of Nephrology ·Antonio Bellasi, Laura Kooienga, Geoffrey A. Block, Emir Veledar, David M. Spiegel, Paolo Raggi	32
18	Increased mortality associated with coronary artery calcium scores and calcium containing phosphate binders: Long term results from a randomized controlled trial in new dialysis patients 2006 ·Nephrology Dialysis Transplantation ·Geoffrey A. Block, (unknown), Antonio Bellasi, James Ehrlich, Michel Chonchol	1
19	Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders 2006 ·Nephrology Dialysis Transplantation ·Alfredo R. Galassi, David M. Spiegel, Antonio Bellasi, Geoffrey A. Block, Paolo Raggi	63
20	Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients 2006 ·Kidney International ·Antonio Bellasi, Emiliana Ferramosca, Paul Muntner, Carlo Ratti, Rachel P. Wildman, Geoffrey A. Block, Paolo Raggi	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact